Primary prevention of cardiovascular disease: The past, present, and future of blood pressure- and cholesterol-lowering treatments
Leening MJG, Ikram MA
PLoS Med. Pub. online 20 March 2018.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
Karmali KN, Lloyd-Jones DM, van der Leeuw J, et al.
PLoS Med. Pub. online 20 March 2018.
Leggi
Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist
Bethel MA, McMurray JJV
Circulation. 2018;137:1218-20
Leggi
Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study
Abrahami D, Douros A, Yin H, et al.
BMJ. 2018;360:k872
Leggi
Individualizing Blood Pressure Targets for People With Diabetes and HypertensionComparing the ADA and the ACC/AHA Recommendations
de Boer IA, Bakris G, Cannon CP
JAMA. Pub. online March 15, 2018.
Leggi
Could FreeStyle Libre™ sensor glucose data support decisions for safe driving?
Rayman G, Kröger J, Bolinder J
Diabetic Medicine. 2018;35(4):491-4
Leggi
Bridging technology and clinical practice: innovating inpatient hyperglycaemia management in non-critical care settings
Thabit H, Hovorka R
Diabetic Medicine. 2018;35(4):460-71
Leggi
Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems
Peters TM, Haidar A
Diabetic Medicine. 2018;35(4):450-9
Leggi
Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review
Farrington C
Diabetic Medicine. 2018;35(4):436-49
Leggi
Transfer from paediatric to adult care for young adults with Type 2 diabetes: the SEARCH for Diabetes in Youth Study
Agarwal S, Raymond JK, Isom S, et al.
Diabetic Medicine. 2018;35(4):504-12
Leggi